RXST

MKT CAP:$298M

RxSight, Inc.

Market Cap

$298M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$7.20-$3.18 (-30.64%)

Apr 23, 2026

Company Details

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight sy...

CEO

Ronald Kurtz

IPO Date

Jul 30, 2021

Website

www.rxsight.com

Key Metrics TTM

Revenue

$142M

+2.7% YoY

Net Income

-$36M

EPS (Diluted)

-$0.88

Free Cash Flow

-$22M

Revenue / Share

$3.47

Gross Margin

75.0%

Operating Margin

-32.0%

Net Margin

-25.1%

FCF Margin

-15.6%

P/S

2.1x

P/E

—

Earnings Reports

Q4 2025

May 6, 2026

PENDING

Q3 2025

Nov 5, 2025

$30M-33.2%EPS -$0.24

Q2 2025

Aug 7, 2025

$34M-3.6%EPS -$0.29

Q1 2025

May 7, 2025

$38M+28.4%EPS -$0.20

FY 2024

Feb 25, 2025

$140M+57.1%EPS -$0.71

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$8M	$3M	-$15M
Q1 22	$9M	$4M	-$17M
Q2 22	$11M	$5M	-$16M
Q3 22	$13M	$5M	-$16M
Q4 22	$16M	$7M	-$15M
Q1 23	$17M	$10M	-$13M
Q2 23	$21M	$12M	-$14M
Q3 23	$31M	$14M	-$13M
Q4 23	$29M	$18M	-$11M
Q1 24	$30M	$21M	-$11M
Q2 24	$35M	$24M	-$8M
Q3 24	$45M	$25M	-$9M
Q4 24	$40M	$29M	-$9M
Q1 25	$38M	$28M	-$11M
Q2 25	$34M	$25M	-$14M
Q3 25	$30M	$24M	-$12M

Valuation

Quarter	P/S	P/E
Q4 21	13.2x	—
Q1 22	10.6x	—
Q2 22	8.6x	—
Q3 22	7.2x	—
Q4 22	6.1x	—
Q1 23	5.2x	—
Q2 23	4.4x	—
Q3 23	3.5x	—
Q4 23	3.1x	—
Q1 24	2.7x	—
Q2 24	2.4x	—
Q3 24	2.2x	—
Q4 24	2.0x	—
Q1 25	1.9x	—
Q2 25	1.9x	—
Q3 25	2.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	-$9M	-$9M
Q1 22	-$15M	-$15M
Q2 22	-$15M	-$16M
Q3 22	-$15M	-$16M
Q4 22	-$14M	-$14M
Q1 23	-$18M	-$19M
Q2 23	-$8M	-$9M
Q3 23	-$8M	-$9M
Q4 23	-$10M	-$11M
Q1 24	-$9M	-$11M
Q2 24	-$4M	-$6M
Q3 24	$730.0K	-$373.0K
Q4 24	-$4M	-$5M
Q1 25	-$9M	-$9M
Q2 25	-$4M	-$6M
Q3 25	-$1M	-$2M

Capital Expenditures

Quarter	CapEx
Q4 21	$365.0K
Q1 22	$370.0K
Q2 22	$1M
Q3 22	$580.0K
Q4 22	$362.0K
Q1 23	$747.0K
Q2 23	$2M
Q3 23	$653.0K
Q4 23	$2M
Q1 24	$2M
Q2 24	$2M
Q3 24	$1M
Q4 24	$847.0K
Q1 25	$575.0K
Q2 25	$2M
Q3 25	$581.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+71.5%	+74.7%
Q1 22	+156.7%	+74.6%
Q2 22	+132.0%	+44.6%
Q3 22	+118.0%	+51.2%
Q4 22	+90.9%	+34.6%
Q1 23	+95.6%	+19.9%
Q2 23	+83.2%	+26.8%
Q3 23	+143.1%	+51.1%
Q4 23	+77.6%	+26.9%
Q1 24	+68.7%	+31.4%
Q2 24	+67.6%	+25.5%
Q3 24	+48.1%	+26.5%
Q4 24	+40.7%	+23.9%
Q1 25	+28.4%	+20.9%
Q2 25	-3.6%	+10.2%
Q3 25	-33.2%	-22.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$3M	34.6%
Q1 22	$3M	29.6%
Q2 22	$3M	25.6%
Q3 22	$3M	22.8%
Q4 22	$3M	18.4%
Q1 23	$3M	18.8%
Q2 23	$4M	19.0%
Q3 23	$4M	13.3%
Q4 23	$4M	15.5%
Q1 24	$5M	15.9%
Q2 24	$6M	17.5%
Q3 24	$7M	14.4%
Q4 24	$7M	18.1%
Q1 25	$7M	18.8%
Q2 25	$9M	25.4%
Q3 25	$8M	26.7%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 21	$6M	$12M
Q1 22	$7M	$14M
Q2 22	$6M	$14M
Q3 22	$6M	$15M
Q4 22	$7M	$16M
Q1 23	$7M	$16M
Q2 23	$7M	$18M
Q3 23	$7M	$19M
Q4 23	$7M	$21M
Q1 24	$8M	$23M
Q2 24	$8M	$24M
Q3 24	$9M	$26M
Q4 24	$9M	$28M
Q1 25	$10M	$29M
Q2 25	$10M	$29M
Q3 25	$9M	$27M

Revenue Segments

Quarter	L D D	Rx LAL	Service Warranty Service Contracts And Accessories
Q1 22	$5M	$4M	$268.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$24M	$120M	$144M
Q2 22	$24M	$105M	$129M
Q3 22	$9M	$104M	$113M
Q4 22	$12M	$94M	$106M
Q1 23	$11M	$143M	$154M
Q2 23	$9M	$138M	$147M
Q3 23	$10M	$122M	$132M
Q4 23	$10M	$117M	$127M
Q1 24	$33M	$93M	$125M
Q2 24	$24M	$209M	$233M
Q3 24	$17M	$220M	$237M
Q4 24	$17M	$221M	$237M
Q1 25	$28M	$201M	$229M
Q2 25	$40M	$187M	$227M
Q3 25	$30M	$198M	$228M
Q4 25	$20M	$208M	$228M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	27M	+46.0%	+43.4%
Q1 22	27M	+0.3%	+43.8%
Q2 22	28M	+0.5%	+4.8%
Q3 22	28M	+0.4%	+47.7%
Q4 22	28M	+1.2%	+2.3%
Q1 23	32M	+13.0%	+15.4%
Q2 23	34M	+9.0%	+25.2%
Q3 23	36M	+3.4%	+28.9%
Q4 23	36M	+0.8%	+28.5%
Q1 24	37M	+2.5%	+16.5%
Q2 24	38M	+4.4%	+11.5%
Q3 24	40M	+3.5%	+11.6%
Q4 24	40M	+1.4%	+12.2%
Q1 25	41M	+0.4%	+10.0%
Q2 25	41M	+0.6%	+5.9%
Q3 25	41M	+0.5%	+3.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$38.1K	221
Q1 22	$40.5K	221
Q2 22	$51.4K	221
Q3 22	$57.1K	221
Q4 22	$55.1K	292
Q1 23	$59.9K	292
Q2 23	$71.3K	292
Q3 23	$105.0K	292
Q4 23	$97.9K	292
Q1 24	$101.1K	292
Q2 24	$119.5K	292
Q3 24	$155.5K	292
Q4 24	$80.8K	498
Q1 25	$76.1K	498
Q2 25	$67.5K	498
Q3 25	$60.9K	498

Revenue / Employee